News
-
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
Onco-Innovations Limited appoints Dr. Dennis Hall, renowned chemist, to Scientific and Clinical Advisory Board. Dr. Hall brings expertise in boron chemistry, catalysis, and drug discovery to advance innovative oncology-focused therapies -
-
COMMUNIQUÉ DE PRESSE
Atos Group publishes estimated 2025 half-year liquidity position reflecting limited cash consumption in the half
Atos Group publishes its estimated 2025 half-year liquidity position, showing limited cash consumption and solid liquidity levels in accordance with reporting requirements -
COMMUNIQUÉ DE PRESSE
Le Groupe Atos publie une estimation de sa position de liquidité à mi 2025 reflétant une consommation de trésorerie limitée sur le semestre
Le Groupe Atos publie une estimation de sa position de liquidité à mi 2025 reflétant une consommation de trésorerie limitée sur le semestre -
-
COMMUNIQUÉ DE PRESSE
Battery X Metals Announces Commercial Revenue Share Agreement for Next-Generation Lithium-Ion Battery Rebalancing Machine Following Estimated Driving Range Increase of ~255 km of Light-Duty Electric Vehicle Model with Severe Cell Imbalance, Restoring Batt
Battery X Metals Inc.'s subsidiary enters Commercial Revenue Share Agreement for lithium-ion battery rebalancing machine. Successful real-world trial confirms 637.5% improvement in driving range -
COMMUNIQUÉ DE PRESSE
Battery X Metals Announces Annual General Meeting Results, Corporate Awareness Agreement, and Initiative to Strengthen Financial Position
Battery X Metals Inc. announces positive voting results from its AGSM and agreements with Apollo Shareholder Relations Ltd. and certain creditors. Details on resolutions and Debt Settlement included -
COMMUNIQUÉ DE PRESSE
ReelTime's RLTR Soars 54% in One Week, Outperforming Every Major AI Stock as Investors Embrace "Reel Intelligence"
RLTR emerges as top-performing AI stock of the week, surpassing major tech players like Microsoft and Amazon. ReelTime's Reel Intelligence platform drives the stock's meteoric rise